171 related articles for article (PubMed ID: 6401591)
1. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
Habs MR; Schmähl D
Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
Brock N; Stekar J
Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
Schmähl D; Habs M; Tacchi AM
Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
Freedman A; Ehrlich RM; Ljung BM
J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
[TBL] [Abstract][Full Text] [Related]
5. The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.
Reuther H; Kohl M; Wildenauer DB
Arzneimittelforschung; 1986 Apr; 36(4):763-5. PubMed ID: 3087373
[TBL] [Abstract][Full Text] [Related]
6. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Brock N; Pohl J
IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.
Schmähl D; Habs MR
Cancer Treat Rev; 1983 Sep; 10 Suppl A():57-61. PubMed ID: 6414697
[No Abstract] [Full Text] [Related]
8. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
Kunze E; Köhnecke B; Engelhardt W; Steinröder H; Brock N; Pohl J
Urol Int; 1984; 39(2):61-7. PubMed ID: 6426112
[TBL] [Abstract][Full Text] [Related]
9. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
Brock N; Pohl J; Stekar J; Scheef W
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1377-87. PubMed ID: 6819957
[TBL] [Abstract][Full Text] [Related]
10. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
Kedar A; Simpson CL; Williams P; Moore R; Tritsch G; Murphy GP
Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389
[TBL] [Abstract][Full Text] [Related]
11. Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells.
Mohrmann M; Ansorge S; Schönfeld B; Brandis M
Pediatr Nephrol; 1994 Aug; 8(4):458-65. PubMed ID: 7524598
[TBL] [Abstract][Full Text] [Related]
12. Renal transport and disposition of Na-2-mercaptoethane sulfonate disulfide (dimesna) in the rat.
Ormstad K; Uehara N
FEBS Lett; 1982 Dec; 150(2):354-8. PubMed ID: 6819161
[TBL] [Abstract][Full Text] [Related]
13. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER
J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
[TBL] [Abstract][Full Text] [Related]
14. Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats.
Slott VL; Hales BF
Toxicol Appl Pharmacol; 1986 Jan; 82(1):80-6. PubMed ID: 3080822
[TBL] [Abstract][Full Text] [Related]
15. The fate of [14C]-mesna in the rat.
Shaw IC; Graham MI; Jones MS
Arzneimittelforschung; 1986 Mar; 36(3):487-9. PubMed ID: 3085684
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo.
Lähdetie J; Räty R; Sorsa M
Mutat Res; 1990 Sep; 245(1):27-32. PubMed ID: 2118231
[TBL] [Abstract][Full Text] [Related]
17. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
Ozcan A; Korkmaz A; Oter S; Coskun O
Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
[TBL] [Abstract][Full Text] [Related]
18. Delayed development of bladder cancer in male SD rats induced with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine following concomitant administration of sodium 2-mercaptoethane sulfonate.
Berger MR; Schmähl D
Cancer Lett; 1986 Sep; 32(3):313-21. PubMed ID: 3094932
[TBL] [Abstract][Full Text] [Related]
19. Excretion of disodium bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosing.
Shaw IC; Weeks MS
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):933-5. PubMed ID: 3117563
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
Ormstad K; Ohno Y
Cancer Res; 1984 Sep; 44(9):3797-800. PubMed ID: 6430554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]